Pharmalytical Summit 2021 - Technical/Others 3. New Molecular Insights into the Solid-State Variability of Warfarin Sodium 2-Propanol Solvate Using a Multivariate and Multi-technique Approach
A primary anti-coagulant narrow therapeutic index drug, warfarin sodium, poses a high risk of thrombosis or excessive bleeding with sudden death. The root cause for these risks is not well established. It has been hypothesized that a freely soluble crystalline warfarin sodium (WARC) transforms to non-crystalline warfarin sodium (WARNC) under stress conditions and that the WARNC can later transform to the poorly soluble un-ionized form. This transformation could directly lead to dissolution failure in-vivo and could be responsible for the increased clinical risks. The study presented here focused on systematically characterizing solid form changes and 2-propanol (IPA) content under different environmental conditions followed by a low volume 2-stage dissolution method to mimic in vivo GIT behavior.
![](https://rigaku.com/hs-fs/hubfs/2024%20Rigaku%20Global%20Site/Banner%20Images/CTA%20Banner/contact_us_stock_1.jpg?width=450&height=450&name=contact_us_stock_1.jpg)
Contact Us
Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.
![](https://rigaku.com/hs-fs/hubfs/2024%20Rigaku%20Global%20Site/Module%20Images/Subscription%20Banner/bridge3_cta_450x450.jpg?width=450&height=450&name=bridge3_cta_450x450.jpg)
Subscribe to the Bridge newsletter
Stay up to date with materials analysis news and upcoming conferences, webinars and podcasts, as well as learning new analytical techniques and applications.